ARTICLE | Company News
BZL Biologics LLC, ImaginAb deal
October 26, 2009 7:00 AM UTC
ImaginAb received a sublicense for BZL's huJ591 for diagnostic imaging. ImaginAb expects to start development of the humanized mAb against prostate-specific membrane antigen ( PSMA) for diagnostics i...